Status:
COMPLETED
Levels of Circulating T Cells Expressing VLA-1 Collagen Receptors
Lead Sponsor:
Sheba Medical Center
Conditions:
Ischemic Heart Disease
Eligibility:
All Genders
18-80 years
Brief Summary
The examination of the percentage of peripheral T cells carrying VLA-1 in ischemic heart disease patients. The hypothesis is that the percentage levels of cells carrying this integrin rise according t...
Detailed Description
Atherosclerosis is considered an inflammatory disease in which lymphocytes have an important role. The study was disigned to find out the changes in T cell levels carrying VLA-1 involvement in this pr...
Eligibility Criteria
Inclusion
- clinical diagnosis of acute MI for group 1
- clinical diagnosis of ACSl for group 2
- clinical diagnosis of Chronic Heart Disease for groups 3 and 4
- Chest pain but normal heart scan for group 5
Exclusion
- none
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
151 Patients enrolled
Trial Details
Trial ID
NCT00708838
Start Date
January 1 2002
End Date
February 1 2007
Last Update
July 2 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.